help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, D.
Right arrow Articles by Weiss, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, D.
Right arrow Articles by Weiss, L. M.

American Journal of Pathology, Vol 140, 769-774, Copyright © 1992 by American Society for Investigative Pathology


REGULAR ARTICLES

Epstein-Barr virus-associated gastric adenocarcinoma

D Shibata and LM Weiss
Department of Pathology, Los Angeles County, University of Southern California Medical Center 90033.

The Epstein-Barr virus (EBV) has been detected in certain types of lymphoma and some epithelial neoplasms including nasopharyngeal lymphoepithelioma, and rare lymphoepithelioma-like carcinomas occurring in a variety of organs including, most recently, the stomach. The authors investigated the possibility that EBV may be present not only in the rare gastric cancers that resemble nasopharyngeal lymphoepithelioma, but also in typical gastric adenocarcinoma. EBV sequences were detected in 22 of 138 (16%) cases of typical gastric adenocarcinoma by polymerase chain reaction and in situ hybridization (ISH) techniques. The EBV genomes were specifically present within the gastric carcinoma cells in an even distribution. The EBV genomes were also present in adjacent dysplastic epithelium but were absent in surrounding lymphocytes, other normal stromal cells, intestinal metaplasia, and normal gastric mucosa. The EBV genomes in the infected gastric carcinoma cells are expressed as EBV RNA was detected by ISH. EBV was most often detected in gastric tumors from men (21%) compared with women (3%). Thus some cases of gastric adenocarcinoma are EBV- associated.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
H-J Delecluse, R Feederle, B O'Sullivan, and P Taniere
Epstein Barr virus-associated tumours: an update for the attention of the working pathologist
J. Clin. Pathol., December 1, 2007; 60(12): 1358 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-L. Tsai, H.-P. Li, Y.-J. Lu, C. Hsueh, Y. Liang, C.-L. Chen, S. W. Tsao, K.-P. Tse, J.-S. Yu, and Y.-S. Chang
Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling
Cancer Res., December 15, 2006; 66(24): 11668 - 11676.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
J. Minoura-Etoh, K. Gotoh, R. Sato, M. Ogata, N. Kaku, T. Fujioka, and A. Nishizono
Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV.
J. Med. Microbiol., July 1, 2006; 55(Pt 7): 905 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Gao, H. Wang, and T. Sairenji
Inhibition of Epstein-Barr Virus (EBV) Reactivation by Short Interfering RNAs Targeting p38 Mitogen-Activated Protein Kinase or c-myc in EBV-Positive Epithelial Cells
J. Virol., November 1, 2004; 78(21): 11798 - 11806.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
Y. Huang, J. S-H Tsung, C.-W. Lin, and T.-Y. Cheng
Intrahepatic Cholangiocarcinoma with Lymphoepithelioma-Like Carcinoma Component
Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 476 - 480.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. El-Guindy and G. Miller
Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta
J. Virol., July 15, 2004; 78(14): 7634 - 7644.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A zur Hausen, B P van Rees, J van Beek, M E Craanen, E Bloemena, G J A Offerhaus, C J L M Meijer, and A J C van den Brule
Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis
J. Clin. Pathol., May 1, 2004; 57(5): 487 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. L. Kutok, S. Klumpp, M. Simon, J. J. MacKey, V. Nguyen, J. M. Middeldorp, J. C. Aster, and F. Wang
Molecular Evidence for Rhesus Lymphocryptovirus Infection of Epithelial Cells in Immunosuppressed Rhesus Macaques
J. Virol., April 1, 2004; 78(7): 3455 - 3461.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. S. Lee, M. S. Chang, H.-K. Yang, B. L. Lee, and W. H. Kim
Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative Carcinoma
Clin. Cancer Res., March 1, 2004; 10(5): 1698 - 1705.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Fukuda and R. Longnecker
Latent Membrane Protein 2A Inhibits Transforming Growth Factor-{beta}1-Induced Apoptosis through the Phosphatidylinositol 3-Kinase/Akt Pathway
J. Virol., February 15, 2004; 78(4): 1697 - 1705.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. van Beek, A. zur Hausen, E. Klein Kranenbarg, C. J.H. van de Velde, J. M. Middeldorp, A. J.C. van den Brule, C. J.L.M. Meijer, and E. Bloemena
EBV-Positive Gastric Adenocarcinomas: A Distinct Clinicopathologic Entity With a Low Frequency of Lymph Node Involvement
J. Clin. Oncol., February 15, 2004; 22(4): 664 - 670.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Etoh, Y. Kanai, S. Ushijima, T. Nakagawa, Y. Nakanishi, M. Sasako, S. Kitano, and S. Hirohashi
Increased DNA Methyltransferase 1 (DNMT1) Protein Expression Correlates Significantly with Poorer Tumor Differentiation and Frequent DNA Hypermethylation of Multiple CpG Islands in Gastric Cancers
Am. J. Pathol., February 1, 2004; 164(2): 689 - 699.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. P. Thompson and R. Kurzrock
Epstein-Barr Virus and Cancer
Clin. Cancer Res., February 1, 2004; 10(3): 803 - 821.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Iwakiri, Y. Eizuru, M. Tokunaga, and K. Takada
Autocrine Growth of Epstein-Barr Virus-Positive Gastric Carcinoma Cells Mediated by an Epstein-Barr Virus-Encoded Small RNA
Cancer Res., November 1, 2003; 63(21): 7062 - 7067.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
X. Chen, S. Y. Leung, S. T. Yuen, K.-M. Chu, J. Ji, R. Li, A. S.Y. Chan, S. Law, O. G. Troyanskaya, J. Wong, et al.
Variation in Gene Expression Patterns in Human Gastric Cancers
Mol. Biol. Cell, August 1, 2003; 14(8): 3208 - 3215.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W.-h. Feng, E. Westphal, A. Mauser, N. Raab-Traub, M. L. Gulley, P. Busson, and S. C. Kenney
Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors
J. Virol., November 1, 2002; 76(21): 10951 - 10959.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Wakisaka, S. Murono, T. Yoshizaki, M. Furukawa, and J. S. Pagano
Epstein-Barr Virus Latent Membrane Protein 1 Induces and Causes Release of Fibroblast Growth Factor-2
Cancer Res., November 1, 2002; 62(21): 6337 - 6344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. P. van Rees, E. Caspers, A. zur Hausen, A. van den Brule, P. Drillenburg, M. A. J. Weterman, and G. J. A. Offerhaus
Different Pattern of Allelic Loss in Epstein-Barr Virus-Positive Gastric Cancer with Emphasis on the p53 Tumor Suppressor Pathway
Am. J. Pathol., October 1, 2002; 161(4): 1207 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
Q N Vo, J Geradts, M L Gulley, D A Boudreau, J C Bravo, and B G Schneider
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation
J. Clin. Pathol., September 1, 2002; 55(9): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-N. Tsai, C.-L. Tsai, K.-P. Tse, H.-Y. Chang, and Y.-S. Chang
The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases
PNAS, July 23, 2002; 99(15): 10084 - 10089.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-h. Feng, B. Israel, N. Raab-Traub, P. Busson, and S. C. Kenney
Chemotherapy Induces Lytic EBV Replication and Confers Ganciclovir Susceptibility to EBV-positive Epithelial Cell Tumors
Cancer Res., March 1, 2002; 62(6): 1920 - 1926.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Maruo, L. Yang, and K. Takada
Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells
J. Gen. Virol., October 1, 2001; 82(10): 2373 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. G. Chu, Y.-Y. Chen, W.-g. Chen, and L. M. Weiss
No Direct Role for Epstein-Barr Virus in American Hepatocellular Carcinoma
Am. J. Pathol., October 1, 2001; 159(4): 1287 - 1292.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
P. G. Chu, K. L. Chang, Y.-Y. Chen, W.-G. Chen, and L. M. Weiss
No Significant Association of Epstein-Barr Virus Infection with Invasive Breast Carcinoma
Am. J. Pathol., August 1, 2001; 159(2): 571 - 578.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
Y. M. D. Lo, W. Y. Chan, E. K. W. Ng, L. Y. S. Chan, P. B. S. Lai, J. S. Tam, and S. C. S. Chung
Circulating Epstein-Barr Virus DNA in the Serum of Patients with Gastric Carcinoma
Clin. Cancer Res., July 1, 2001; 7(7): 1856 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Trivedi, P. Spinsanti, L. Cuomo, M. Volpe, K. Takada, L. Frati, and A. Faggioni
Differential Regulation of Epstein-Barr Virus (EBV) Latent Gene Expression in Burkitt Lymphoma Cells Infected with a Recombinant EBV Strain
J. Virol., May 15, 2001; 75(10): 4929 - 4935.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
A A T P Brink, C J L M Meijer, J M Nicholls, J M Middeldorp, and A J C van den Brule
Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders
Mol. Pathol., April 1, 2001; 54(2): 98 - 102.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. Janz, M. Oezel, C. Kurzeder, J. Mautner, D. Pich, M. Kost, W. Hammerschmidt, and H.-J. Delecluse
Infectious Epstein-Barr Virus Lacking Major Glycoprotein BLLF1 (gp350/220) Demonstrates the Existence of Additional Viral Ligands
J. Virol., November 1, 2000; 74(21): 10142 - 10152.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
P G Murray and L S Young
Themed issue: the biology and pathology of the Epstein-Barr virus
Mol. Pathol., October 1, 2000; 53(5): 219 - 221.
[Full Text]


Home page
Mol. Pathol.Home page
K Takada
Epstein-Barr virus and gastric carcinoma
Mol. Pathol., October 1, 2000; 53(5): 255 - 261.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
E. M. Westphal, W. Blackstock, W. Feng, B. Israel, and S. C. Kenney
Activation of Lytic Epstein-Barr Virus (EBV) Infection by Radiation and Sodium Butyrate in Vitro and in Vivo: A Potential Method for Treating EBV-positive Malignancies
Cancer Res., October 1, 2000; 60(20): 5781 - 5788.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. z. Hausen, A. A. T. P. Brink, M. E. Craanen, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule
Unique Transcription Pattern of Epstein-Barr Virus (EBV) in EBV-carrying Gastric Adenocarcinomas: Expression of the Transforming BARF1 Gene
Cancer Res., May 1, 2000; 60(10): 2745 - 2748.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
R. F. Ambinder
Gammaherpesviruses and ""Hit-and-Run"" Oncogenesis
Am. J. Pathol., January 1, 2000; 156(1): 1 - 3.
[Full Text] [PDF]


Home page
ASH Education BookHome page
G. Franchini, R. F. Ambinder, and M. Barry
Viral Disease in Hematology
Hematology, January 1, 2000; 2000(1): 409 - 423.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. T.K.-H. Stadtlander and J. W. waterbor
Molecular epidemiology, pathogenesis and prevention of gastric cancer
Carcinogenesis, December 1, 1999; 20(12): 2195 - 2208.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E.-M. Westphal, A. Mauser, J. Swenson, M. G. Davis, C. L. Talarico, and S. C. Kenney
Induction of Lytic Epstein-Barr Virus (EBV) Infection in EBV-associated Malignancies Using Adenovirus Vectors in Vitro and in Vivo
Cancer Res., April 1, 1999; 59(7): 1485 - 1491.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Nishikawa, S. Imai, T. Oda, T. Kojima, K. Okita, and K. Takada
Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression
J. Virol., February 1, 1999; 73(2): 1286 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. W. Dawson, J. Dawson, R. Jones, K. Ward, and L. S. Young
Functional Differences between BHRF1, the Epstein-Barr Virus-Encoded Bcl-2 Homologue, and Bcl-2 in Human Epithelial Cells
J. Virol., November 1, 1998; 72(11): 9016 - 9024.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Komano, M. Sugiura, and K. Takada
Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt's Lymphoma Cell Line Akata
J. Virol., November 1, 1998; 72(11): 9150 - 9156.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Iwasaki, J.-M. Chong, Y. Hayashi, R. Ikeno, K. Arai, M. Kitamura, M. Koike, K. Hirai, and M. Fukayama
Establishment and Characterization of a Human Epstein-Barr Virus-Associated Gastric Carcinoma in SCID Mice
J. Virol., October 1, 1998; 72(10): 8321 - 8326.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Imai, J. Nishikawa, and K. Takada
Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells
J. Virol., May 1, 1998; 72(5): 4371 - 4378.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
G. D. Clark, Yoke Sun Lee, K.-W. Min, and S. T. Dunn
Epstein-Barr Virus in Gastric Carcinomas from Singapore
International Journal of Surgical Pathology, January 1, 1996; 4(3): 149 - 158.
[Abstract] [PDF]


Home page
INT J SURG PATHOLHome page
J. K. C. Chan, T. T. C. Yip, W. Y. W. Tsang, S. Seneviratne, Y.F. Poon, C. S. C. Wong, and V. W. S. Ma
Lack of Evidence of Pathogenetic Role of Epstein-Barr Virus in Thymic Lymphoid Hyperplasia and Thymomas in the Chinese Population of Hong Kong
International Journal of Surgical Pathology, July 1, 1994; 2(1): 17 - 22.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Murono, H. Inoue, T. Tanabe, I. Joab, T. Yoshizaki, M. Furukawa, and J. S. Pagano
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells
PNAS, June 5, 2001; 98(12): 6905 - 6910.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.